Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Drug Cardiotoxicity Screening. ASCR [Internet]. 2023 Feb. 7 [cited 2026 Oct. 31];6(1):1-6. Available from: https://somatopub.com/index.php/ASCR/article/view/353